These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15916116)

  • 1. A comparison of the quality of life of hearing-impaired people as estimated by three different utility measures.
    Barton GR; Bankart J; Davis AC
    Int J Audiol; 2005 Mar; 44(3):157-63. PubMed ID: 15916116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints.
    Grutters JP; Joore MA; van der Horst F; Verschuure H; Dreschler WA; Anteunis LJ
    Qual Life Res; 2007 Oct; 16(8):1439-49. PubMed ID: 17647093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing utility scores before and after hearing-aid provision : results according to the EQ-5D, HUI3 and SF-6D.
    Barton GR; Bankart J; Davis AC; Summerfield QA
    Appl Health Econ Health Policy; 2004; 3(2):103-5. PubMed ID: 15702947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
    Wong CKH; Lang BHH; Yu HMS; Lam CLK
    Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index.
    O'Brien BJ; Spath M; Blackhouse G; Severens JL; Dorian P; Brazier J
    Health Econ; 2003 Nov; 12(11):975-81. PubMed ID: 14601159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the HUI3 and the EQ-5D-3L in a nursing home setting.
    Lung T; Howard K; Etherton-Beer C; Sim M; Lewin G; Arendts G
    PLoS One; 2017; 12(2):e0172796. PubMed ID: 28234983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D.
    Sach TH; Barton GR; Doherty M; Muir KR; Jenkinson C; Avery AJ
    Int J Obes (Lond); 2007 Jan; 31(1):189-96. PubMed ID: 16682976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.
    Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N
    Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
    Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
    Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Condition Impacts in a Nationally Representative Cross-Sectional Survey Vary Substantially by Preference-Based Health Index.
    Hanmer J; Cherepanov D; Palta M; Kaplan RM; Feeny D; Fryback DG
    Med Decis Making; 2016 Feb; 36(2):264-74. PubMed ID: 26314728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordance in Utility Measurement in Persons with Neurological Conditions: A Comparison of the SF-6D and the HUI3.
    Abel H; Kephart G; Packer T; Warner G
    Value Health; 2017 Sep; 20(8):1157-1165. PubMed ID: 28964449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.
    Xie F; Li SC; Luo N; Lo NN; Yeo SJ; Yang KY; Fong KY; Thumboo J
    Arthritis Rheum; 2007 Aug; 57(6):1043-9. PubMed ID: 17665466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing short form 6D, standard gamble, and Health Utilities Index Mark 2 and Mark 3 utility scores: results from total hip arthroplasty patients.
    Feeny D; Wu L; Eng K
    Qual Life Res; 2004 Dec; 13(10):1659-70. PubMed ID: 15651537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of EQ-5D and SF-6D utilities in Pompe disease.
    Kanters TA; Redekop WK; Kruijshaar ME; van der Ploeg AT; Rutten-van Mölken MP; Hakkaart L
    Qual Life Res; 2015 Apr; 24(4):837-44. PubMed ID: 25342117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD).
    Gerhards SA; Huibers MJ; Theunissen KA; de Graaf LE; Widdershoven GA; Evers SM
    Value Health; 2011; 14(5):732-9. PubMed ID: 21839412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A head-to-head comparison of EQ-5D-5 L and SF-6D in Chinese patients with low back pain.
    Ye Z; Sun L; Wang Q
    Health Qual Life Outcomes; 2019 Apr; 17(1):57. PubMed ID: 30971265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the measurement properties and estimation of minimal important differences of the EQ-5D and SF-6D utility measures in patients with systemic sclerosis.
    Kwakkenbos L; Fransen J; Vonk MC; Becker ES; Jeurissen M; van den Hoogen FH; van den Ende CH
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):50-6. PubMed ID: 23910610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.